ISM3091 An investigational USP1 inhibitor discovered by Insilico and licensed to Exelixis in 2023.
Visit productCosigns Received
Be the first Cosign
Put your name behind ISM3091.
Add it to your Products I use list and share why you use it.
ISM3091 An investigational USP1 inhibitor discovered by Insilico and licensed to Exelixis in 2023.
Visit productBe the first Cosign
Add it to your Products I use list and share why you use it.